Do advertisements for antihypertensive drugs in Australia promote quality prescribing? : a cross-sectional study

Brett Montgomery, P.R. Mansfield, G.K. Spurling, A.M. Ward

    Research output: Contribution to journalArticle

    15 Citations (Scopus)
    223 Downloads (Pure)

    Abstract

    Background: Antihypertensive medications are widely prescribed by doctors and heavily promoted by the pharmaceutical industry. Despite strong evidence of the effectiveness and cost-effectiveness of thiazide diuretics, trends in both promotion and prescription of antihypertensive drugs favour newer, less costeffective agents. Observational evidence shows correlations between exposure to pharmaceutical promotion and less ideal prescribing. Our study therefore aimed to determine whether print advertisements for antihypertensive medications promote quality prescribing in hypertension. Methods: We performed a cross-sectional study of 113 advertisements for antihypertensive drugs from 4 general practice-oriented Australian medical publications in 2004. Advertisements were evaluated using a quality checklist based on a review of hypertension management guidelines. Main outcome measures included: frequency with which antihypertensive classes were advertised, promotion of thiazide class drugs as first line agents, use of statistical claims in advertisements, mention of harms and prices in the advertisements, promotion of assessment and treatment of cardiovascular risk, promotion of lifestyle modification, and targeting of particular patient subgroups. Results: Thiazides were the most frequently advertised drug class (48.7% of advertisements), but werelargely promoted in combination preparations. The only thiazide advertised as a single agent was the most expensive, indapamide. No advertisement specifically promoted any thiazide as a better first-line drug. Statistics in the advertisements tended to be expressed in relative rather than absolute terms. Drug costs were often reported, but without cost comparisons between drugs. Adverse effects were usually reported but largely confined to the advertisements' small print. Other than mentioning drug interactions with alcohol and salt, no advertisements promoted lifestyle modification. Few advertisements (2.7%) promoted the assessment of cardiovascular risk. Conclusion: Print advertisements for antihypertensive medications in Australia provide some, but not all, of the key messages required for guideline-concordant care. These results have implications for the regulation of drug advertising and the continuing education of doctors.
    Original languageEnglish
    Pages (from-to)online - approx 5-20pp
    JournalBMC Public Health
    Volume8
    Issue number167
    DOIs
    Publication statusPublished - 2008

    Fingerprint Dive into the research topics of 'Do advertisements for antihypertensive drugs in Australia promote quality prescribing? : a cross-sectional study'. Together they form a unique fingerprint.

    Cite this